Medicare Official to Speak on Improving Outcomes

Jonathan Blum

/kidneynews/5_10_11/23b/graphic/23bf1.jpg

An expert on Medicare will deliver the Christopher R. Blagg Endowed Lectureship in Renal Disease and Public Policy. Jonathan Blum’s topic will be “Improving Standards and Quality Outcomes: The Federal Government in Action.”

As acting principal deputy administrator and director of the Center for Medicare at the Centers for Medicare & Medicaid Services (CMS), Blum is responsible for overseeing the regulation and payment of Medicare fee-for-service providers, privately administered Medicare health plans, and the Medicare prescription drug program. These programs pay for health care for more than 50 million elderly and disabled Americans, with an annual budget in the hundreds of billions of dollars.

Over the course of his career, Blum has become an expert in the gamut of CMS programs. He served as an advisor to the Senate Finance Committee, where he worked on prescription drug and Medicare Advantage policies during the development of the Medicare Modernization Act of 2003. That act was one of the largest-ever overhauls of Medicare, and introduced Medicare Part D, the prescription drug benefit. He focused on Medicare as a program analyst at the White House Office of Management and Budget. Prior to joining CMS, he was a vice president at Avalere Health, overseeing its Medicaid and long-term care practice.

He holds a master’s degree from the Kennedy School of Government and a bachelor’s degree from the University of Pennsylvania.

Notes

[1] ASN gratefully acknowledges the Northwest Kidney Centers and its contributors for support of the Christopher R. Blagg Endowed Lectureship in Renal Disease and Public Policy.


October-November 2013 (Vol. 5, Number 10 & 11)